Company information:
Renovos Biologics Limited (No: 10685524)
Status: Active
Incorporated: 22-Mar-2017
Accounts Next Due: 31-Dec-2024
Next Confirmation Statement Due: 12-Jun-2024
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: MICHAEL HARRIS ( DOB: May-1970 From: Jun-2023 )
Current Director: AGNIESZKA ALEKSANDRA JANECZEK ( DOB: Apr-1987 From: Sep-2022 )
Current Director: RICHARD OREFFO ( DOB: Sep-1961 From: Mar-2017 )
Current Director: JAMES ANTHONY OTTER ( DOB: Nov-1957 From: Mar-2017 )
Current Director: SIMON SINCLAIR ( DOB: May-1972 From: Apr-2019 )
Resigned Director: PETER JOHN SHAND SMITH ( DOB: Jun-1954 From: Dec-2017 To: Apr-2019 )
Persons of Significant Control:
University Of Southampton Holdings Limited, Building 37 Finance Department University Of Southampton, Highfield, Southampton, Hampshire, SO17 1BJ, England: Has significant influence or control (Notified: 2017-10-31, Ceased: 2023-06-26)
Prof Richard Oreffo, The Catalyst Centre 2 Venture Road, Southampton Science Park, Chilworth, Southampton, SO16 7NP, United Kingdom: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2017-03-22, Ceased: 2017-10-31)
Otter James, The Catalyst Centre 2 Venture Road, Southampton Science Park, Chilworth, Southampton, SO16 7NP, United Kingdom: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2017-03-22, Ceased: 2017-10-20)
Jonathan Dawson, The Catalyst Centre 2 Venture Road, Southampton Science Park, Chilworth, Southampton, SO16 7NP, United Kingdom: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2017-03-22, Ceased: 2017-10-31)
Company Accounts Summary (£)
| Item | 18 | 19 | 20 | 21 | 22 | 23 | 24 | Chart |
|---|---|---|---|---|---|---|---|---|
| Current assets | 47,726 | 71,159 | 133,846 | 117,637 | 101,590 | 60,943 | 685,697 | 47726,71159,133846.0,117637.0,101590.0,60943.0,685697.0 |
| Current assets / Cash at bank and on hand | 41,977 | 29,235 | 72,687 | 41,284 | 65,665 | 15,828 | 646,676 | 41977,29235,72687.0,41284.0,65665.0,15828.0,646676.0 |
| Net current assets (liabilities) | 34,018 | 43,959 | 122,124 | 108,366 | 83,250 | 47,163 | 670,085 | 34018,43959,122124.0,108366.0,83250.0,47163.0,670085.0 |
| Total assets less current liabilities | 34,018 | 91,167 | 34018,91167,0.0,0.0,0.0,0.0,0.0 | |||||
| Net assets (liabilities) | 34,018 | 91,167 | 171,431 | 145,370 | 107,951 | 59,561 | 679,055 | 34018,91167,171431.0,145370.0,107951.0,59561.0,679055.0 |
| Equity / share capital and reserves | 34,018 | 91,167 | 171,431 | 145,370 | 107,951 | 59,561 | 679,055 | 34018,91167,171431.0,145370.0,107951.0,59561.0,679055.0 |